Moderiba (AbbVie Inc.)
Welcome to the PulseAid listing for the Moderiba drug offered from AbbVie Inc.. This Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AbbVie Inc. |
| NON-PROPRIETARY NAME: | Ribavirin |
| SUBSTANCE NAME: | RIBAVIRIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2014-01-20 |
| END MARKETING DATE: | 0000-00-00 |
Moderiba HUMAN PRESCRIPTION DRUG Details:
| Item Description | Moderiba from AbbVie Inc. |
| LABELER NAME: | AbbVie Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 2014-01-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0074-3197_e4ee4ce1-25b5-0379-6e24-31a76c3a0cc9 |
| PRODUCT NDC: | 0074-3197 |
| APPLICATION NUMBER: | ANDA077456 |
Other RIBAVIRIN Pharmaceutical Manufacturers / Labelers:
